KCNN4 and diabetic kidney disease: The administration of TRAM34 significantly reversed the upregulated KCa3.1 expression in diabetic nephropathy (DN+TRAM34) compared to that of vehicle-treated mice (DN+DMSO) (P<0.01, Fig 1B).